Citations for
1TSG16H
Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
Fromont G, Valeri A, Cher M, Pontes JE, Vallancien G, Validire P, Latil A, Cussenot O.
Prostate 65(4):341-6. 2005
2TSG10B, TSG12C, TSG13D, TSG14C, CRAC1, TSG16H, TSG19A, TSG1A
Detection of three novel translocations and specific common chromosomal break sites in malignant melanoma by spectral karyotyping.
Sargent LM, Nelson MA, Lowry DT, Senft JR, Jefferson AM, Ariza ME, Reynolds SH.
Genes Chromosomes Cancer 32(1):18-25. 2001
3TSG16H
Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus.
Paris PL, Witte JS, Kupelian PA, Levin H, Klein EA, Catalona WJ, Casey G.
Cancer Res 60(13):3645-9. 2000
4TSG16B, TSG16H
Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer.
Li C, et al.
Genes Chromosomes Cancer 24 : 175-182. 1999
5TSG16H
Identification of a 910-Kb region of common allelic loss in chromosome bands 16q24.1-q24.2 in human lung cancer.
Sato M, et al.
Genes Chromosomes Cancer 22 : 1-8. 1998
6CDH13, TSG16H
The H-cadherin (CDH13) gene is inactivated in human lung cancer.
Sato M, et al.
Hum Genet 103 : 96-101. 1998
7TSG16B, TSG16H
Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.
Grundy RG, et al.
Br J Cancer 78 : 1181-1187. 1998
8TSG16H
Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer.
Elo JP, Harkonen P, Kyllonen AP, Lukkarinen O, Poutanen M, Vihko R, Vihko P.
Cancer Res 57(16):3356-9. 1997